|
|
Drugs for Vein Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 1280)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Iron | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1123 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 2 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 3624 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 3 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 2829 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 4 | | Doxorubicin | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 1714 | 23214-92-8 | 31703 | (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione 111266-55-8 14-Hydroxydaunomycin 14-Hydroxydaunorubicine 14-hydroxydaunomycin 14-hydroxydaunorubicine 23214-92-8 23257-17-2 24385-08-8 25311-50-6 25316-40-9 25316-40-9 (hydrochloride) 29042-30-6 AC1L1M5T AC1Q29OJ ADM ADR Adriablastin Adriacin (hydrochloride salt) Adriamycin Adriamycin PFS Adriamycin PFS (hydrochloride salt) Adriamycin RDF Adriamycin RDF (hydrochloride salt) Adriamycin Semiquinone Adriamycin semiquinone Adriblas tina Adriblastin Adriblastina Adriblastina (TN) Adriblastina (hydrochloride salt) Aerosolized Doxorubicin BPBio1_000502 BRD-K92093830-003-04-3 BSPBio_000456 BSPBio_001031 C01661 C27H29NO11 CCRIS 739 CHEBI:28748 CHEMBL179 CID31703 Caelyx Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 D03899 DB00997 DM2 DOX-SL Doxil Doxo Doxorubicin Doxorubicin (USAN/INN) Doxorubicin HCl | Doxorubicin Hydrochloride Doxorubicin [USAN:INN:BAN] Doxorubicin citrate Doxorubicin hydrochloride (hydrochloride salt) Doxorubicin-P4/D10 Doxorubicin-P4/D10 conjugate Doxorubicin-hLL1 Doxorubicin-hLL1 conjugate Doxorubicina Doxorubicina [INN-Spanish] Doxorubicine Doxorubicine [INN-French] Doxorubicinum Doxorubicinum [INN-Latin] EINECS 245-495-6 FI 106 Farmablastina (hydrochloride salt) HMS2089H06 HSDB 3070 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) Hydroxydaunomycin hydrochloride (hydrochloride salt) Hydroxydaunorubicin Hydroxydaunorubicin hydrochloride (hydrochloride salt) JT9100000 LMPK13050001 LS-1029 LS-165655 MLS000759533 Myocet NCI-C01514 NChemBio.2007.10-comp13 NDC 38242-874 NIOSH/JT9100000 NSC 123127 Prestwick0_000438 Prestwick1_000438 Prestwick2_000438 Prestwick3_000438 Probes1_000151 Probes2_000129 RDF Rubex Resmycin Rubex Rubex (hydrochloride salt) SMP1_000106 SPBio_002395 TLC D-99 ThermoDox Triferric doxorubicin UNII-80168379AG adiblastine (hydrochloride salt) adr iablatina (hydrochloride salt) adriablastine (hydrochloride salt) adriablatina (hydrochloride salt) adriblatina (hydrochloride salt) doxorubicin nchembio809-comp5 |
| | 5 | | Idarubicin | approved | Phase 4, Phase 2, Phase 1 | 210 | 58957-92-9 | 42890 | (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione 4-DMD 4-Demethoxydaunomycin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin 57852-57-0 57852-57-0 (HYDROCHLORIDE) 58957-92-9 AC1L28SA AC1Q6JJ4 BRD-K69650333-001-01-1 C26H27NO9 CCRIS 5083 CHEBI:42068 CHEMBL1117 CID42890 D08062 DB01177 DM5 DMDR EU-0100600 HMS2089D05 I 1656 I06-1097 I1656_SIGMA IDARUBICIN | IMI 30 IMI-30 Idamycin Idamycin PFS Idarubicin (INN) Idarubicin Aglycone Idarubicin HCl PFS Idarubicin Hcl Idarubicin Hcl Pfs Idarubicin Hydrochloride Idarubicin [INN:BAN] Idarubicina Idarubicina [INN-Spanish] Idarubicine Idarubicine [INN-French] Idarubicinum Idarubicinum [INN-Latin] KBioSS_002388 LS-94015 Lopac0_000600 MLS000759470 NCGC00093976-01 NCGC00093976-02 NCGC00093976-03 NCGC00093976-04 NSC-256439 NSC256439 SMR000466355 UNII-ZRP63D75JW Zavedos Zavedos (TN) idarubicin hydrochloride |
| | 6 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1518 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-Methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
| | 7 | | Cisplatin | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 2690 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 8 | | Tinzaparin | approved | Phase 4, Phase 2, Phase 3 | 37 | 9005-49-6, 9041-08-1 | 25244225 | 101921-26-0 102-94-3 102785-31-9 104521-37-1 11078-24-3 11129-39-8 12656-11-0 37324-73-5 9041-08-1 9045-22-1 9075-96-1 913079-23-9 91449-79-5 AC1L1ROY ALFA 87-120 ALFA 87-163 ALFA 87-198 ALFA 87-81 ALFA 88-247 Allocinnamic acid Ardeparin Ardeparin sodium Arteven Bemiparin Bemiparin sodium CID8784 CY 216 Certoparin Clivarin Clivarine Cy 222 Dalteparin Dalteparin sodium Depo-Heparin EINECS 232-681-7 Enoxaparin sodium Eparina Eparina [DCIT] FR 860 Fluxum Fragmin A Fragmin B Fragmin IV Fraxiparin H 2149 HSDB 3094 Hed-heparin Hep Flush Kit in plastic container Hep-Lock Hep-Lock U/P Heparin CY 216 Heparin Lock Flush Heparin Lock Flush in plastic container Heparin Lock Flush preservative free Heparin Lock Flush preservative free in plastic container Heparin natrium Heparin sodium Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container Heparin sodium 1,000 units in dextrose 5% in plastic container Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container Heparin sodium 10,000 units in dextrose 5% Heparin sodium 10,000 units in dextrose 5% in plastic container Heparin sodium 10,000 units in sodium chloride 0.45% Heparin sodium 10,000 units in sodium chloride 0.9% Heparin sodium 12,500 units in dextrose 5% Heparin sodium 12,500 units in dextrose 5% in plastic container Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container Heparin sodium 12,500 units in sodium chloride 0.9% Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container Heparin sodium 2,000 units in dextrose 5% in plastic container Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container Heparin sodium 20,000 units and dextrose 5% in plastic container Heparin sodium 20,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units and dextrose 5% in plastic container Heparin sodium 25,000 units in dextrose 5% Heparin sodium 25,000 units in dextrose 5% in plastic container | Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container Heparin sodium 25,000 units in sodium chloride 0.9% Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container Heparin sodium 5,000 units in dextrose 5% in plastic container Heparin sodium 5,000 units in sodium chloride 0.45% Heparin sodium 5,000 units in sodium chloride 0.9% Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container Heparin sodium in plastic container Heparin sodium preservative Free Heparin sulfate Heparin, sodium salt Heparina Heparina [INN-Spanish] Heparinate Heparine Heparine [INN-French] Heparinic acid Heparinum Heparinum [INN-Latin] Heparinum natricum Hepathrom Hepflush-10 Inno-Hep Innohep Isocinnamic acid KB 101 Kabi 2165 LHN 1 Lioton 1000 Lipo-hepin Liquaemin Liquaemin Lock Flush Liquaemin Sodium Liquaemin sodium preservative free Liquemin Logiparin Minolteparin sodium MolPort-003-760-257 Multiparin NSC174025 Nadroparin Nadroparine Novoheparin OP 386 OP 622 Octaparin Pabyrin Panheprin Parnaparin Parnaparin sodium Parvoparin Pularin Reviparin Reviparin sodium Ro 11 Sandoparin Sodium acid heparin Sodium heparin Sodium heparinate Subeparin Sublingula Thromboliquine Tinzaparin Tinzaparin sodium Triofiban UNII-12M44VTJ7B UNII-3S182ET3UA UNII-E47C0NF7LV UNII-T2410KM04A UNII-ZZ45AB24CA Vetren Vitrum AB WY 90493RD alpha-Heparin cis-.beta.-Carboxystyrene cis-Cinnamic acid heparin |
| | 9 | | Chlorhexidine | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 472 | 55-56-1 | 9552079, 2713 | 1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide] 1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide) 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane 1,6-Bis(p-chlorophenyldiguanido)hexane 1,6-Di(4'-chlorophenyldiguanido)hexane 1,6-Di(N-p-chlorophenyldiguanido)hexane 24798_FLUKA 282227_ALDRICH 348031_ALDRICH 4-12-00-01201 (Beilstein Handbook Reference) 55-56-1 AB00053427 AB1003159 AVAGARD BPBio1_000272 BRN 2826432 BSPBio_000246 BSPBio_001977 C06902 C22H30Cl2N10 CAS-55-56-1 CCRIS 9230 CHEBI:3614 CHEMBL790 CID9552079 Chlorhexidin Chlorhexidin [Czech] Chlorhexidine Chlorhexidine (INN) Chlorhexidine Base Chlorhexidine [INN:BAN] Chlorhexidine gluconate Chlorhexidinum Chlorhexidinum [INN-Latin] Cloresidina Cloresidina [DCIT] Clorhexidina Clorhexidina [INN-Spanish] D07668 DB00878 Decanoylacetaldehyde Sodium Sulfide Dentisept [veterinary] Dentisept [veterinary] (TN) DivK1c_000761 EINECS 200-238-7 Fimeil HMS1568M08 HSDB 7196 Hexadol Hibiclens Hibispray Hibistat I06-0621 I14-0050 IDI1_000761 | KBio1_000761 KBio2_000717 KBio2_003285 KBio2_005853 KBio3_001197 KBioGR_000774 KBioSS_000717 LS-43917 Lisium (*Dihydrochloride*) MK-412A MLS001332387 MLS001332388 MLS002154209 Merfen-incolore Merfen-incolore (TN) MolPort-002-541-741 N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide NCGC00016246-01 NCGC00091025-01 NCGC00091025-02 NINDS_000761 NSC526936 Nolvasan Nolvasan (*Diacetate*) Novalsan Oro-Clense Peridex Periogard Prestwick0_000143 Prestwick1_000143 Prestwick2_000143 Prestwick3_000143 Prestwick_53 QTL1_000020 Rotersept SMR000857146 SPBio_000210 SPBio_002185 STK089248 STOCK1S-18831 Savloclens Savlon babycare Sebidin A Sodium Houttuyfonamide Soretol Spectrum2_000135 Spectrum3_000339 Spectrum4_000277 Spectrum5_001322 Spectrum_000237 Sterido Sterilon Superspray Tubulicid UNII-R4KO0DY52L chlorhexidine |
| | 10 | | Propranolol | approved, investigational | Phase 4, Phase 3, Phase 2 | 216 | 525-66-6 | 4946 | (+-)-Propranolol (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol (R)-(+)-propranolol (S)-(-)-PROPRANOLOL 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol 13013-17-7 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI) 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI) 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol 4199-09-1 4199-10-4 525-66-6 AB00053537 AC1L1JA4 AC1Q1QBV AC1Q1QC0 AKOS000588816 AY 64043 AY-20694 Anaprilin Anapriline Angilol Apsolol Avlocardyl BPBio1_001040 BRD-A10070317-003-06-9 BSPBio_000944 BSPBio_002682 Bedranol Beprane Berkolol Beta Neg Beta-Neg Beta-Propranolol Beta-Tablinen Beta-Timelets Betachron Betadren Betalong Bio-0732 Bio1_000367 Bio1_000856 Bio1_001345 C07407 C16H21NO2 CBDivE_006180 CCRIS 3082 CHEBI:8499 CHEMBL27 CID4946 Cardinol Caridolol Corpendol D,L-Propranolol D08443 DB00571 DL-Propranolol hydrochloride Deralin DivK1c_000023 Dl-Propranolol Hydrochloride Dociton Duranol EINECS 208-378-0 EINECS 235-867-6 Efektolol Elbrol Etalong Euprovasin Frekven HMS2090L21 Herzbase ICI 45520 IDI1_000023 INDERIDE-40/25 INDERIDE-80/25 Ikopal Inderal Inderal La Inderal hydrochloride Inderalici Inderex Inderide Inderol Indobloc InnoPranXL | Innopran XL Intermigran KBio1_000023 KBio2_002515 KBio2_005083 KBio2_007651 KBio3_001766 KBio3_001902 KBio3_002993 KBioGR_001347 KBioGR_001684 KBioGR_002515 KBioSS_002523 Kemi Kemi S L000679 LS-122410 LS-184129 Lopac0_000896 Migrastat MolPort-001-794-623 NCGC00015798-07 NCGC00024690-02 NCGC00024690-03 NINDS_000023 NSC91523 Naprilin Obsidan Obzidan Oposim Oprea1_304193 PDSP1_000767 PDSP1_001607 PDSP1_001608 PDSP2_000755 PDSP2_001591 PDSP2_001592 Prano-Puren Pranolol Prestwick0_000952 Prestwick1_000952 Prestwick2_000952 Prestwick3_000952 Pronovan Propanalol Propanix Propanolol Propanolol [INN-Spanish] Prophylux Propranalol Propranolol Propranolol (INN) Propranolol (TN) Propranolol Hcl Propranolol Hcl Intensol Propranolol Hydrochloride Propranolol [INN:BAN] Propranololo Propranololo [DCIT] Propranololum Propranololum [INN-Latin] Propranur Proprasylyt Pylapron R,S-Propranolol Hydrochloride Racemic propranolol Rapynogen Reducor Reducor Line Reducor line SPBio_001361 SPBio_001658 SPBio_003093 STK735510 Sagittol Sawatal Servanolol Sloprolol Spectrum2_001301 Spectrum2_001699 Spectrum3_000883 Spectrum3_001071 Spectrum4_000974 Spectrum4_001222 Spectrum5_000751 Sumial Tesnol UNII-9Y8NXQ24VQ b-Propranolol beta-Propranolol cMAP_000071 etalong propranolol propranololo β-Propranolol |
| | 11 | | Bevacizumab | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1968 | 216974-75-3 | | 216974-75-3 Avastin Avastin (TN) Bevacizumab Bevacizumab (genetical recombination) | Bevacizumab (genetical recombination) (JAN) D06409 R-435 anti-VEGF monoclonal antibody antiVEGF bevacizumab | |
| | 12 | | Everolimus | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1896 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 13 | | Pantoprazole | approved | Phase 4 | 172 | 102625-70-7 | 4679 | 102625-70-7 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole AC-679 AC1L1IPJ Astropan BIDD:GT0003 BRD-A22380646-001-01-5 BSPBio_002320 BY 1023 BY-1023 C11806 C16H15F2N3O4S CHEBI:519598 CHEBI:7915 CHEMBL1502 CID4679 D05353 DB00213 HMS1922H20 HMS2090H03 HMS2093F14 HSDB 7292 I06-0068 LS-32883 MolPort-003-666-752 MolPort-005-933-577 NCGC00095188-01 | NCGC00095188-02 NCGC00095188-03 Pantoloc Pantopan Pantoprazol Pantoprazol [INN-Spanish] Pantoprazole (USAN/INN) Pantoprazole Na Pantoprazole Sodium Pantoprazole Sodium Hydrate Pantoprazole [USAN:BAN:INN] Pantoprazole sodium Pantoprazolum Pantoprazolum [INN-Latin] Pantoprozole Pantor Pantozol Protium Protonix Protonix I.V. Protonix IV SBB070993 SK&F 96022 SK&F-96022 SK-96022 SKF-96022 SPECTRUM1505818 Somac TL8000127 UNII-D8TST4O562 pantoprazole |
| | 14 | | Omeprazole | approved, investigational, vet_approved | Phase 4, Phase 2, Phase 3 | 337 | 73590-58-6 | 4594 | ( -)-Omeprazole (-)-Omeprazole (S)-(-)-Omeprazole (S)-Omeprazole 119141-89-8 131959-78-9 172964-80-6 2,3,5-Trimethylpyridine/Omeprazole 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole 73590-58-6 AC-401 AC1L1IIJ AGI-010 AKOS005066653 AULCER Antra Antra MUPS Audazol Aulcer Axagon BIDD:GT0189 BPBio1_000425 BRD-A55962179-001-04-9 BSPBio_000385 Belmazol Bio-0888 C07324 CAS-73590-58-6 CCRIS 7099 CHEBI:519601 CHEBI:7772 CHEMBL1503 CID4594 CPD000058847 Ceprandal D00455 DB00338 DB00736 DM-3458 Danlox Demeprazol Desec Dizprazol Dudencer Elgam Emeproton Emilok Epirazole Erbolin Esomeprazole Esomperazole Esopral Exter Gasec Gastrimut Gastroloc Gibancer H 168-68 H 168/68 H-168/68 H168/68 HMS1528I05 HMS1569D07 HMS2052G17 HMS2090E16 HMS2090F11 HSDB 3575 I06-0705 IDI1_032523 Indurgan Inhibitron Inhipump LS-7629 Lensor Logastric Lomac Losec Losec, Omesec, Prilosec, Zegerid, Omeprazole Lucen MLS000069373 MLS001076112 MLS001424148 Maybridge4_002645 Mepral Miol Miracid MolPort-003-666-741 MolPort-003-807-515 MolPort-003-849-702 Mopral Morecon NCGC00016925-01 | NCGC00016925-02 NCGC00021522-03 NCGC00021522-04 NCGC00021522-05 Nexiam Nexium Nexium IV Nilsec Nopramin Nuclosina O0359 O104_SIGMA OMEP OMP OMZ Ocid Olexin Olit Omapren Omebeta Omebeta 20 Omed Omegast Omepradex Omepral Omeprazol Omeprazol [INN-Spanish] Omeprazole Omeprazole (JAN/USP/INN) Omeprazole Pellets Omeprazole [USAN:INN:BAN:JAN] Omeprazole delayed-release Omeprazole magnesium Omeprazolum Omeprazolum [INN-Latin] Omeprazon Omeprazone Omeprol Omesek Omez Omezol Omezolan Omid Omisec Omizac Ompanyt Ortanol Osiren Ozoken Paprazol Parizac Pepticum Pepticus Peptilcer Prazentol Prazidec Prazolit Prestwick0_000493 Prestwick1_000493 Prestwick2_000493 Prestwick3_000493 Prestwick_808 Prilosec Prilosec (TN) Prilosec OTC Procelac Proclor Prysma Ramezol Regulacid Result S1389_Selleck SAM001246900 SAN-15 SMR000058847 SPBio_002306 STK623746 Sanamidol Secrepina TL8005099 Tedec Ulceral UNII-KG60484QX9 UPCMLD-DP075 UPCMLD-DP075:001 Ulceral Ulcesep Ulcometion Ulcozol Ulcsep Ulsen Ultop Ulzol Victrix Zefxon Zegerid Zepral Zimor Zoltum esomeprazol omeprazole |
| | 15 | | Bupivacaine | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 1131 | 2180-92-9, 38396-39-3 | 2474 | ( inverted exclamation markA)-bupivacaine (+-)-Bupivacaine (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (RS)-bupivacaine (±)-bupivacaine 1-Butyl-2',6'-pipecoloxylidide 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 15233-43-9 2180-92-9 38396-39-3 AB00053674 AC-2096 AC1L1DRE AC1Q5LX4 AH 250 AKOS001637202 AR-1A0242 Anekain BPBio1_000298 BRD-A01636364-003-05-2 BSPBio_000270 BSPBio_002607 Bio-0886 Bloqueina Bucaine Bucaine (TN) Bupivacaina Bupivacaina [INN-Spanish] Bupivacaine (INN) Bupivacaine Carbonate Bupivacaine HCL Bupivacaine HCL KIT Bupivacaine Monohydrochloride, Monohydrate Bupivacaine [INN:BAN] Bupivacainum Bupivacainum [INN-Latin] Bupivan C07529 C18H28N2O CBupivacaine CHEBI:3215 CHEMBL1098 CID2474 Carbostesin D07552 DB00297 DL-Bupivacaine DUR-843 | DepoBupivacaine DivK1c_000758 EINECS 218-553-3 EINECS 253-911-2 HMS2090F12 IDI1_000758 KBio1_000758 KBio2_002004 KBio2_004572 KBio2_007140 KBio3_001827 KBioGR_001516 KBioSS_002004 KST-1A4609 L000695 LAC-43 LS-109841 LS-2222 MLS001361336 Marcaina Marcaine Marcaine HCL Marcaine Spinal MolPort-004-955-820 NCGC00178579-01 NCGC00178579-02 NINDS_000758 NSC119660 Prestwick0_000305 Prestwick1_000305 Prestwick2_000305 Prestwick3_000305 SMR000058218 SPBio_001558 SPBio_002489 Sensorcaine Sensorcaine-MPF Sensorcaine-MPF Spinal Spectrum2_001589 Spectrum3_000974 Spectrum4_001098 Spectrum5_001483 Spectrum_001524 Transdur-Bupivacaine UNII-Y8335394RO Win 11318 Win 11318 HCl bupivacaine cBupivacaine dl-1-Butyl-2',6'-pipecoloxylidide racemic bupivacaine |
| | 16 | | Ceftriaxone | approved | Phase 4, Phase 3, Phase 2 | 114 | 73384-59-5 | 5479530, 5361919 | (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 104376-79-6 104376-79-6 (di-hydrochloride salt) 73384-59-5 74578-69-1 (di-hydrochloride salt, hemiheptahydrate) 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid AC-1592 AC1NUIFE Biotrakson C06683 C18H18N8O7S3 CEFTRIAXONE SODIUM CHEBI:29007 CHEMBL161 CID5479530 CTRX Cefatriaxone Ceftriaxon Ceftriaxona Ceftriaxona [INN-Spanish] | Ceftriaxone (INN) Ceftriaxone (TN) Ceftriaxone [USAN:JAN] Ceftriaxone intravenous Ceftriaxone, Disodium Salt Ceftriaxone, Disodium Salt, Hemiheptahydrate Ceftriaxonum Ceftriaxonum [INN-Latin] Ceftriazone D07659 DB01212 DRG-0071 EINECS 277-405-6 LS-150031 Longacef Longaceph MolPort-005-933-495 Ro 139904 Ro-13-9904 Ro13-9904 Rocefin Rocephin Rocephine UNII-75J73V1629 ceftriaxone |
| | 17 | | Sirolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1896 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 18 | | Daunorubicin | approved | Phase 4, Phase 2 | 264 | 20830-81-3 | 30323 | (+)-Daunomycin (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 11006-54-5 11048-29-6 1407-15-4 149541-57-1 20830-81-3 23942-76-9 27576-81-4 28020-80-6 AB00514669 AC1L1JCP AC1Q29OI AI3-52942 Acetyladriamycin Anthracyline Antibiotics From Streptomyces Coeruleorubidus Antibiotics from Streptomyces coeruleorubidus BPBio1_000389 BRD-K43389675-003-02-7 BRN 1445583 BSPBio_000353 C01907 CCRIS 914 CHEBI:41977 CHEMBL178 CID30323 Cerubidin Cerubidine D07776 DAUNORUBICIN HCL DB00694 DM1 Daunamycin Daunarubicinum Dauno-Rubidomycine DaunoXome DaunoXome (TN) Daunoblastin Daunoblastine Daunomycin | Daunomycin Hydrochloride Daunomycin, Hydrochloride Daunorrubicina Daunorubicin Daunorubicin (INN) Daunorubicin (liposomal) Daunorubicin Hcl Daunorubicin Hydrochloride Daunorubicin [INN:BAN] Daunorubicin, Hydrochloride Daunorubicina Daunorubicine Daunorubicinum Daunorubicinum [INN-Latin] Daunoxome EINECS 244-069-7 FI 6339 FI6339 HMS2089H04 HMS2091K06 HSDB 5095 LMPK13050002 LS-187381 LS-997 Leukaemomycin C MolPort-002-533-961 NCGC00024246-05 NCGC00024246-06 NCGC00025173-01 NCI-C04693 NChemBio.2007.10-comp14 NSC 83142 NSC-82151 Ondena Prestwick3_000487 RCRA waste no. U059 RP 13057 Rcra Waste No. U059 Rp 13057 Hydrochloride Rubidomycin Rubidomycin Hydrochloride Rubomycin Rubomycin C Tocris-1467 UNII-ZS7284E0ZP VS-103 daunorubicin nchembio723-comp2 |
| | 19 | | Ticlopidine | approved | Phase 4, Phase 3, Phase 2 | 457 | 55142-85-3 | 5472 | 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine 55142-85-3 AC-15204 AC1L1KFB BIDD:PXR0169 BPBio1_000191 BRD-K00603606-003-03-4 BRN 1216802 BSPBio_000173 C07140 C14H14ClNS CAS-53885-35-1 CHEBI:9588 CHEMBL833 CID5472 D08594 DB00208 EINECS 259-498-5 HMS2089I18 L001108 LS-152434 MLS001201825 MolPort-002-507-849 | NCGC00016872-01 NCGC00016872-02 NCGC00024361-04 PCR 5332 Prestwick0_000047 Prestwick1_000047 Prestwick2_000047 Prestwick3_000047 SMR000641861 SPBio_002094 STK589340 STOCK5S-54105 Ticlid Ticlopidin-Puren Ticlopidin-Puren (TN) Ticlopidina Ticlopidina [INN-Spanish] Ticlopidine (INN) Ticlopidine HCL Ticlopidine Hydrochloride Ticlopidine [INN:BAN] Ticlopidinum Ticlopidinum [INN-Latin] UNII-OM90ZUW7M1 UNM-0000345023 ZINC19594599 ticlopidine | |
| | 20 | | Nicorandil | approved | Phase 4 | 17 | 65141-46-0 | 47528 | 2 Nicotinamidethyl Nitrate 2 Nicotinamidoethyl Nitrate 2-(Nicotinamido)ethyl nitrat 2-(Pyridine-3-carboxamido)ethyl Nitrate 2-(pyridine-3-carbonylamino)ethyl nitrate 2-Nicotinamidethyl Nitrate 2-Nicotinamidoethyl nitrate 2-[(pyridin-3-ylcarbonyl)amino]ethylnitrat 65141-46-0 AC-4690 AC1L2I8U AC1Q5PMV AKOS001589705 ARONIS24318 Adancor Aventis Brand of Nicorandil Aventis Pharma Brand of Nicorandil BRD-K97752965-001-01-6 BRN 0481451 Bio-0696 C13280 C8H9N3O4 CHEMBL284906 CID47528 CPD000466365 D01810 D020108 Dancor EINECS 265-514-1 HMS2051N16 HMS2089L12 I06-0032 Ikorel LS-130673 | MLS000759488 MLS001424162 MLS002222323 Merck Brand of Nicorandil Merck Lipha Sante Brand of Nicorandil MolPort-000-829-178 N-(2-Hydroxyethyl)nicotinamide nitrate N-(2-Hydroxyethyl)nicotinamide nitrate (ester) N-[2-(Nitrooxy)ethyl]pyridine-3-carboxamide N0837 NCGC00025357-01 NCGC00025357-02 NICORANDIL Nicorandil (JP15/USAN/INN) Nicorandil Aventis Brand Nicorandil Merck Brand Nicorandil [USAN:BAN:INN:JAN] Nicorandilum Nicorandilum [INN-Latin] Nitrate, 2-Nicotinamidethyl Nitrate, 2-Nicotinamidoethyl RP-46417 Rhone Poulenc Rorer Brand of Nicorandil Rhone-Poulenc Rorer Brand of Nicorandil S1971_Selleck SAM001246701 SG 75 SG-75 SG75 SMR000466365 Sigmart Sigmart (TN) TL8004616 Tocris-2147 ZINC01533102 | |
| | 21 | | Esmolol | approved | Phase 4 | 55 | 103598-03-4, 81147-92-4 | 59768 | (+-)-Esmolol (+-)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate (±)-esmolol (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate 103598-03-4 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester 81147-92-4 81161-17-3 (Hydrochloride) 84057-94-3 AC-12058 AC1L1RWQ AC1Q5ZXA ASL 8052-001 BRN 5287174 Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester C06980 CHEBI:4856 | CHEMBL768 CID59768 D07916 DB00187 ESMOLOL Esmolol (INN) Esmolol [INN:BAN] HMS2090P06 L001332 LS-185019 LS-31121 Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate MolPort-005-933-593 UNII-MDY902UXSR methyl 3-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]propanoate methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate methyl p-[2-hydroxy-3-(isopropylamino)propoxy]hydrocinnamate |
| | 22 | | Nicardipine | approved | Phase 4 | 30 | 55985-32-5 | 4474 | 2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 55985-32-5 AB00514658 AC-19947 AC1L1I8Y AKOS001637090 Ambap55985-32-5 BIDD:GT0621 BPBio1_000623 BRD-A26711594-001-02-7 BRD-A26711594-003-05-6 BRN 0504321 BSPBio_000565 BSPBio_001389 BSPBio_002943 Bio1_000088 Bio1_000577 Bio1_001066 Bio2_000109 Bio2_000589 C07264 C26H29N3O6 CBiol_001802 CHEBI:507549 CHEMBL1484 CID4474 Cardene Cardene (TN) Cardene IV D08270 DB00622 DivK1c_000540 EINECS 259-932-3 HMS1791F11 HMS1989F11 HMS2089C09 IDI1_000540 IDI1_033859 KBio1_000540 | KBio2_000109 KBio2_001852 KBio2_002677 KBio2_004420 KBio2_005245 KBio2_006988 KBio3_000217 KBio3_000218 KBio3_002443 KBioGR_000109 KBioGR_000744 KBioSS_000109 KBioSS_001852 L000715 LS-131263 Lopac0_000809 MolPort-002-484-049 NCGC00015747-06 NCGC00162262-01 NCGC00162262-02 NCGC00162262-03 NCGC00162262-04 NINDS_000540 Nicardipine (INN) Nicardipine LA Nicardipine [INN:BAN] Nicardipino Nicardipino [INN-Spanish] Nicardipinum Nicardipinum [INN-Latin] Oprea1_436998 Prestwick0_000383 Prestwick1_000383 Prestwick2_000383 Prestwick3_000383 SPBio_001490 SPBio_002486 Spectrum2_001415 Spectrum3_001452 Spectrum4_000422 Spectrum5_001320 Spectrum_001372 UNII-CZ5312222S Y-93 methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate nicardipine |
| | 23 | | Propofol | approved, investigational, vet_approved | Phase 4, Phase 2, Phase 3 | 1028 | 2078-54-8 | 4943 | 2, 6-Diisopropylphenol 2,6 Diisopropylphenol 2,6-Bis(1-methylethyl)phenol 2,6-Bis(Isopropyl)-phenol 2,6-DIISOPROPYLPHENOL 2,6-Diisopropyl phenol 2,6-Diisopropylphenol 2,6-bis(1-methylethyl)-phenol 2,6-di(propan-2-yl)phenol 2078-54-8 28449-97-0 4-06-00-03435 (Beilstein Handbook Reference) 50356-15-5 AB00513968 AC-2038 AC1L1J9Y AC1Q1OUI AI3-26295 AM-149 Abbott Brand of Propofol Alpha Brand of Propofol Ampofol Aquafol Astra Brand of Propofol AstraZeneca Brand of Propofol BIDD:GT0436 BPBio1_000950 BPBio1_000969 BRD-K82255054-001-03-5 BRN 1866484 BSPBio_000862 Biomol-NT_000248 Braun Brand of Propofol C07523 C12H18O CAS-2078-54-8 CCRIS 9000 CHEBI:44915 CHEMBL526 CID4943 CPD-11437 CPD000059151 Curamed Brand of Propofol D00549 D015742 D0617 D126608 D126608_ALDRICH DB00818 DDS-04F Diisopropylphenol Dipravan Diprivan Diprivan (TN) Diprivan Injectable emulsion Disoprivan Disoprofol EINECS 218-206-6 EU-0100437 Fresenius Brand of Propofol Fresenius Kabi Brand of Propofol Fresofol HMS1570L04 HMS2089O21 HMS2094E17 | HSDB 7123 ICI 35,868 ICI 35868 ICI-35,868 ICI-35868 ICI35,868 ICI35868 InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H Ivofol Jsp004266 Juste Brand of Propofol LS-996 Lopac-D126608 Lopac0_000437 MLS001066348 MLS001335999 MLS002454360 MolPort-001-794-517 NCGC00015389-01 NCGC00015389-02 NCGC00015389-04 NCGC00015389-09 NCGC00091538-01 NCGC00091538-02 NCGC00091538-03 NCGC00091538-04 NCGC00091538-05 NCGC00091538-06 NSC 5105 NSC5105 PFL Parnell Brand of Propofol Pisa Brand of Propofol Prestwick0_000931 Prestwick1_000931 Prestwick2_000931 Prestwick3_000931 Propofol Propofol (JAN/USAN/INN) Propofol Abbott Propofol Fresenius Propofol IDD-D Propofol MCT Propofol Rovi Propofol [USAN:INN:BAN] Propofol(2,6-Diisopropylphenol) Propofol-Lipuro Propofolum Propofolum [Latin] Rapinovet Recofol Rovi Brand of Propofol S01-0189 SAM002264610 SMR000059151 SPBio_003031 SPECTRUM1505022 ST50405911 Schering Brand of Propofol UNII-YI7VU623SF W505102_ALDRICH ZD-0859 ZINC00968303 Zeneca Brand of Propofol ghl.PD_Mitscher_leg0.558 nchembio.552-comp7 propofol |
| | 24 | | Fludarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1113 | 21679-14-1, 75607-67-9 | 30751 | (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-F-ARAA 2-F-ara-A 2-Fluoro Ara-A 2-Fluoro-9-beta-D-arabinofuranosyladenine 2-fluoro ARA-A 21679-14-1 9-beta-D-Arabinofuranosyl-2-fluoroadenine 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI) AC1LCW8I AC1Q51CF C10H12FN5O4 CCRIS 3382 CHEMBL1568 CID657237 CPD000058874 D07966 EINECS 244-525-5 F-Ara-A FAMP FT-0082766 FaraA Fludara Fludara, Fludarabine | Fludarabina Fludarabina [Spanish] Fludarabine Fludarabine (INN) Fludarabine 5'-monophosphate Fludarabine [INN] Fludarabine monophosphate Fludarabine phosphate Fludarabinum Fludarabinum [Latin] Fludura Fluradosa Fluradosa (TN) HSDB 6964 I14-4978 LS-15061 MLS000028687 NSC 118218 NSC 118218H NSC-118218 S1491_Selleck SAM002548956 SMR000058874 SQ Fludarabine UNII-1X9VK9O1SC UNII-P2K93U8740 ZINC04216238 | |
| | 25 | | Cytarabine | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 1093 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosyl Cytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine Cytarabine (JP15/USP/INN) | Cytarabine [USAN:INN:BAN:JAN] Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 26 | | Carboplatin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1980 | 41575-94-4 | 10339178, 498142, 38904 | (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum /h1-3H2,(H,7,8)(H,9,10) /q 1,1-Cyclobutanedicarboxylate diammine platinum (II) 1,1-Cyclobutanedicarboxylate diammine platinum(II) 2*-1 2*1H2 41575-94-4 70903-55-8 AC-1457 AC1L8I6U Ambap41575-94-4 BSPBio_003145 C 2538 C2043 C2538_SIGMA C6H10N2O4Pt CBDCA CCRIS 3404 CHEBI:31355 CHEMBL1351 CHEMBL288376 CID10339178 CID2567 CID38904 CID426756 CID498142 CID5352133 CID6398587 CID6603770 Carbopaltin Carboplatin Carboplatin (JAN/USP/INN) Carboplatin (USAN) Carboplatin [USAN:INN:BAN:JAN] Carboplatine Carboplatine [French] Carboplatino Carboplatino [Spanish] Carboplatinum Carboplatinum [Latin] Cbdca Cyclobutane-1,1-dicarboxylate D01363 DB00958 Diammine(1,1-cyclobutanedicarboxylato)platinum (II) Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum Diammine-1,1-cyclobutane dicarboxylate platinum II DivK1c_000892 EINECS 255-446-0 EU-0100230 Ercar HMS1921J16 HMS2090M05 HMS2092B22 HMS502M14 HSDB 6957 I14-2390 IDI1_000892 IUPAC: Azane InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6 | JM 8 JM-8 KBio1_000892 KBio2_002009 KBio2_004577 KBio2_007145 KBio3_002645 KBioGR_000713 KBioSS_002009 LS-117689 Lopac-C-2538 Lopac0_000230 MolPort-003-665-501 MolPort-003-845-609 NCGC00015223-01 NCGC00093695-01 NCGC00094961-01 NCGC00094961-02 NCGC00094961-03 NCGC00162099-01 NCGC00162099-02 NCGC00167800-01 NCGC00178242-01 NINDS_000892 NSC 201345 NSC 241240 NSC-241240 NSC201345 NSC241240 Paraplatin Paraplatin (TN) Paraplatin, Carboplatin Paraplatin-AQ Platinum(+2) Cation Platinum(II), (1, 1-cyclobutanedicar Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2) Platinum, {diammine[1,1-cyclobut S1215_Selleck SPBio_000716 SPECTRUM1502106 Spectrum2_000898 Spectrum3_001503 Spectrum4_000337 Spectrum5_001094 Spectrum_001529 UNII-BG3F62OND5 azanide carboplatin cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II) cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii) cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II) cis-Diammine(1,1-cyclobutanedicarboxylato) platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diammine(cyclobutanedicarboxylato)platinum II cyclobutane-1,1-dicarboxylic acid diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum nchembio.573-comp10 nchembio773-comp2 nchembio873-comp3 platinum(2+) |
| | 27 | | Vidarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 512 | 24356-66-9 | 32326, 21704 | (+)-Cyclaradine .beta.-Adenosine .beta.-D-Adenosine 1odi 2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol 2946-52-3 2fqy 2gl0 30143-02-3 3080-29-3 3228-71-5 4005-33-8 46946-45-6 46969-16-8 524-69-6 5536-17-4 58-61-7 9-Arabinosyladenine 9-beta-D-Arabinofuranosyl-9H-purin-6-amine 9-beta-D-Arabinofuranosyl-adenine 9-beta-D-Arabinofuranosyladenine 9-beta-D-arabinofuranosyl-adenine 9-β-D-arabinofuranosyl-9H-purin-6-amine 9-β-D-arabinofuranosyladenine A 9251 A0152 A4036_SIGMA A4676_SIGMA A5762_SIGMA A9251_SIGMA AC1L18OL AC1L1U8O AC1L2IWM AC1L2SCM AC1O4WIN AC1O8PY7 AC1Q1ID3 AC1Q4Y1Z AC1Q52XU ADENOSINE, U.S.P. ADN AI3-52413 AI3-52821 AR-1H6029 ARA-A NSC 247519 Ade-Rib Adenine Arabinoside Adenine arabinoside Adenine nucleoside Adenine riboside Adenine xyloside Adenocard Adenocard (TN) Adenocard, Adenosine Adenocor Adenoscan Adenoscan (TN) Adenosin Adenosin [German] Adenosine (JAN/USP) Adenosine [USAN:BAN] Adenosine arabinose Adenosine-8-14C Adensoine Ambap5536-17-4 Ara A Ara-A Ara-ATP Araadenosine Arabinoside Adenine Arabinoside adenine Arabinosyl Adenine Arabinosyl adenine Arabinosyl-adenine Arabinosyladenine Arasena-A Armes Armes (TN) BB_NC-0565 BPBio1_000898 BRN 0624881 BSPBio_000816 BSPBio_001796 BSPBio_002000 Bio1_000437 Bio1_000926 Bio1_001415 Boniton C00212 CAS-5536-17-4 CCRIS 2557 CCRIS 3383 CHEBI:136932 CHEBI:16335 CHEBI:45327 CHEMBL1090 CHEMBL20247 CHEMBL477 CI 673 CI-673 CID102198 CID191 CID21704 CID60961 CID6420052 CID6713976 CPD000471872 Caswell No. 010B D000241 D00045 D06298 DB00640 DivK1c_000191 EINECS 200-389-9 EINECS 217-911-6 EINECS 226-893-9 EU-0100123 FT-0082881 HMS1570I18 HMS1920A13 HMS1921K05 HMS2090F06 HMS2091G13 HMS2092C16 HMS500J13 HSDB 6514 | I01-1121 IDI1_000191 KBio1_000191 KBio2_002418 KBio2_004986 KBio2_007554 KBio3_001296 KBio3_001500 KBioGR_001224 KBioSS_002424 L000094 LS-15059 LS-15085 Lopac0_000123 MEDR-640 MLS000069638 MLS000699527 MLS001066352 MLS001333133 MLS001333134 MLS002153227 MLS002153992 MolPort-001-785-903 MolPort-001-838-229 MolPort-003-666-308 Myocol NCGC00016656-01 NCGC00023673-03 NCGC00023673-04 NCGC00023673-05 NCGC00023673-06 NCGC00023673-07 NCGC00094579-01 NCGC00094579-02 NCGC00094579-03 NCGC00094579-04 NCGC00178869-01 NCGC00179417-01 NCI60_003823 NCI60_037192 NCIOpen2_003303 NCIOpen2_005376 NINDS_000191 NSC 247519 NSC 404241 NSC 627048 NSC 7359 NSC 7652 NSC-404241 NSC247519 NSC404241 NSC627048 NSC70422 NSC7359 NSC7652 NSC80832 NSC87676 NSC91041 Nucleocardyl PDSP1_001036 PDSP2_001020 Pallacor Polyadenosine Polyriboadenosine Prestwick0_000768 Prestwick1_000768 Prestwick2_000768 Prestwick3_000768 Prestwick_983 RAB S1647_Selleck S1784_Selleck SAM002564191 SMP1_000312 SMR000058216 SMR000225041 SMR000471872 SMR001233326 SPBio_001194 SPBio_001491 SPBio_002755 SPECTRUM1500107 SPECTRUM1500609 SR 96225 SR-96225 STK361815 SUN-Y4001 Sandesin Spectrum2_001257 Spectrum2_001336 Spectrum3_000288 Spectrum3_000580 Spectrum4_000782 Spectrum5_001429 Spectrum_001894 Spongoadenosine TL8003749 UNII-3XQD2MEW34 UNII-K72T3FS567 USAF CB-10 V0098 VIRDARABINE Vidarabin Vidarabina Vidarabina [DCIT] Vidarabine Vidarabine (JAN) Vidarabine anhydrous Vidarabinum Vira ATM Vira-A Vira-A, Vidarabine XA Xylosyl A Xylosyladenine ZINC00970363 ZINC02169830 adenine-D-ribose adenosine alpha-Ara A beta-Adenosine beta-Ara A beta-D-Adenosine bmse000061 nchembio.143-comp9 nchembio.186-comp109 nchembio.64-comp4 nchembio706-5 |
| | 28 | | Ethiodized oil | approved | Phase 4, Phase 2, Phase 3 | 92 | 8008-53-5 | | | | 29 | | Ethanol | approved | Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1 | 2043 | 64-17-5 | 702 | (C6-C9)Alkyl alcohol 02483_FLUKA 02851_FLUKA 02853_FLUKA 02854_FLUKA 02855_FLUKA 02856_FLUKA 02856_SIAL 02857_FLUKA 02857_SIAL 02858_FLUKA 02858_SIAL 02860_FLUKA 02865_FLUKA 02865_SIAL 02870_FLUKA 02870_SIAL 02875_FLUKA 02877_FLUKA 02878_FLUKA 02882_FLUKA 02882_SIAL 02883_FLUKA 02884_FLUKA 02890_FLUKA 02890_SIAL 02891_FLUKA 02891_SIAL 1-Hydroxyethane 100C.NPA 121182-78-3 187380_ALDRICH 187380_SIAL 24102_RIEDEL 24102_SIAL 24103_RIEDEL 24103_SIAL 24105_RIEDEL 24105_SIAL 24106_RIEDEL 24106_SIAL 24194_RIEDEL 24194_SIAL 245119_ALDRICH 245119_SIAL 270741_ALDRICH 270741_SIAL 277649_ALDRICH 277649_SIAL 2858_SIGMA 29221_FLUKA 32205_RIEDEL 32205_SIAL 32221_RIEDEL 32221_SIAL 32294_RIEDEL 32294_SIAL 34870_SIAL 34963_RIEDEL 39278_FLUKA 40210_ALDRICH 40210_RIEDEL 41322_FLUKA 458600_ALDRICH 458600_SIAL 459828_ALDRICH 459828_SIAL 459836_ALDRICH 459836_SIAL 459844_SIAL 48075_SUPELCO 493511_SIAL 493538_ALDRICH 493538_SIAL 493546_ALDRICH 493546_SIAL 64-17-5 676829_SIAL 68475-56-9 71076-86-3 71329-38-9 8000-16-6 8024-45-1 AC1L19TW AC1Q31MM AHD 2000 AI3-01706 ALCOHOL 5% IN D5-W Absolute Alcohol Absolute Ethanol Absolute alcohol Absolute ethanol Absolute ethyl alcohol Aethanol Aethanol [German] Aethylalkohol Alcare Hand Degermer Alcohol Alcohol (USP) Alcohol (ethyl) Alcohol Anhydrous Alcohol [USP] Alcohol anhydrous Alcohol dehydrated Alcohol denatured Alcohol etílico Alcohol, Absolute Alcohol, Dehydrated Alcohol, Diluted Alcohol, Grain Alcohol, anhydrous Alcohol, dehydrated Alcohol, denatured Alcohol, diluted Alcohol, ethyl Alcohols Alcohols, C1-3 Alcohols, C30 Alcohols, C6-9 Alcool Ethylique Alcool Etilico Alcool ethylique Alcool etilico Alcool éthylique Algrain Alkohol Alkohol [German] Alkoholu Etylowego Alkoholu etylowego Aminoethanol Anhydrol Anhydrol PM 4085 Anhydrous alcohol Anhydrous ethanol Beta-Aminoethanol Beta-Aminoethyl Alcohol Beta-Ethanolamine Beta-Hydroxyethylamine C00469 C2H5OH C2H6O CCRIS 945 CDA 19 CDA 19-200 CHEBI:16236 CHEMBL545 CID702 Caswell No. 426 Caswell No. 430 Colamine Cologne Spirit Cologne spirit Cologne spirits | D000431 D00068 DB00898 Dehydrated Ethanol Dehydrated alcohol Dehydrated ethanol Denatured Alcohol Denatured Alcohol Cd-10 Denatured Alcohol Cd-5 Denatured Alcohol Cd-5a Denatured Alcohol Sd-1 Denatured Alcohol Sd-13a Denatured Alcohol Sd-17 Denatured Alcohol Sd-23a Denatured Alcohol Sd-28 Denatured Alcohol Sd-30 Denatured Alcohol Sd-39b Denatured Alcohol Sd-39c Denatured Alcohol Sd-3a Denatured Alcohol Sd-40m Denatured Ethanol Denatured alcohol Denatured ethanol Desinfektol EL Diluted Alcohol Distilled spirits E2385_SIGMA E7023_ALDRICH E7023_SIAL E7148_ALDRICH E7148_SIAL E7517_SIGMA EINECS 200-578-6 EINECS 270-649-4 EOH EOX ETA Envision Conditioner Pdd 9020 Esumiru WK 88 EtOH Etanolo Etanolo [Italian] Ethanol (9CI) Ethanol 200 Proof Ethanol 200 proof Ethanol Absolute Ethanol Absolute Bp Ethanol Anhydrous Ethanol Extra Pure Ethanol Vapor Ethanol [JAN] Ethanol solution Ethanol, Silent Spirit Ethanol, undenatured Ethanolum anhydricum Ethicap Ethyl Alcohol Ethyl Alcohol & Water, 10% Ethyl Alcohol & Water, 20% Ethyl Alcohol & Water, 30% Ethyl Alcohol & Water, 40% Ethyl Alcohol & Water, 5% Ethyl Alcohol & Water, 50% Ethyl Alcohol & Water, 60% Ethyl Alcohol & Water, 70% Ethyl Alcohol & Water, 80% Ethyl Alcohol & Water, 95% Ethyl Alcohol & Water, 96% Ethyl Alcohol Anhydrous Ethyl Alcohol, Anhydrous Ethyl Alcohol, Denatured Ethyl Hydrate Ethyl Hydroxide Ethyl alc Ethyl alcohol Ethyl alcohol anhydrous Ethyl alcohol in alcoholic beverages Ethyl alcohol usp Ethyl hydrate Ethyl hydroxide Ethylalcohol Ethylalcohol [Dutch] Ethylol Ethylolamine Ethyloxy Group Etylowy alkohol FEMA No. 2419 FEMA Number 2419 Fermentation alcohol Glycinol Grain alcohol HSDB 531 HSDB 82 HYDROXYETHYL GROUP Hinetoless Hydroxyethane I14-12648 IMS 99 Infinity Pure Jaysol Jaysol S LS-1539 LTBB002977 Lux Methylated Spirit Mineralised Methylated spirit Methylcarbinol MolPort-001-785-844 Molasses alcohol NCGC00091458-01 NCI-C03134 NSC 85228 NSC85228 Oxydimethylene Group Potato alcohol Punctilious ethyl alcohol Pyro QMHAIh@ Reagent Alcohol Ru-Tuss Expectorant SDA 3A SDA 40-2 SDM No. 37 SY Fresh M Sekundasprit Silent spirit Spirit Spirits of wine Spiritus vini Spirt Synasol Tecsol Tecsol C Thanol Thiofaco M-50 UNII-3K9958V90M USAF EK-1597 Undenatured Ethanol WLN: Q2 absolute alcohol alcohol alcohol etilico bmse000297 etanol ethanol ethyl alcohol grain alcohol nchem.651-comp3c nchembio.552-comp10 nchembio.94-comp20 spiritus vini Äthanol Äthylalkohol éthanol | |
| | 30 | | Bivalirudin | approved, investigational | Phase 4, Phase 2, Phase 1 | 67 | 128270-60-0 | 16129704 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-cyclohexylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-3-cyclohexylpropanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid 128270-60-0 Angiomax BG 8967 BG-8967 BG8967 Bivalirudin Bivalirudin [USAN:BAN:INN] C074619 C9H11NO.C2H6.CH4 CHEBI:59173 D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-L-leucine | DB02351 HS-2004 Hirulog Hirulog-1 LS-172701 Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu Phe-Pro-Arg-Pro-(Gly)4-desulfohirudin-(53-64) The Medicines Company brand of bivalirudin UNII-TN9BEX005G bivalirudina bivalirudine bivalirudinum | |
| | 31 | | Triamcinolone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 482 | 124-94-7 | 31307 | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione 124-94-7 4-08-00-03629 (Beilstein Handbook Reference) 83474-03-7 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-16-alpha-hydroxyprednisolone 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-16alpha-hydroxyprednisolone 9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione 9α-fluoro-16α-hydroxyprednisolone AC-2072 AC1L1LDH AC1Q5HJC Adcortyl Aristocort Aristocort A Aristocort Tablets Aristogel Aristospan Azmacort BPBio1_000154 BRD-K77554836-001-03-3 BRN 2341955 BSPBio_000140 Bio-0662 C21H27FO6 CHEMBL1451 CID31307 CL 19823 Celeste Cinolone Cinolone-T D00385 D014221 DB00620 Delphicort EINECS 204-718-7 EU-0101179 Fluoxiprednisolone Fluoxyprednisolone Flutex Fougera HMS1568G22 HMS2090D12 HSDB 3194 Kenacort Kenacort (TN) Kenacort-A Kenacort-AG Kenacort-Ag Kenalog Kenalog in Orabase Kenalog-10 Kenalog-40 Kenalog-H LS-698 Ledercort Lopac0_001179 | MLS000028542 MLS001066543 MLS002695935 MolPort-002-528-981 Mycolog NCGC00021580-03 NCGC00021580-04 NCGC00021580-05 NCGC00021580-06 NCGC00021580-07 NCI60_000750 NSC 13397 NSC13397 Nasacort Nasacort Aq Nasacort Hfa Omcilon Omicilon Oracort Oralone Orion Polcortolon Pregna-1,4-diene-3,20-dio Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha) Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI) Prestwick0_000120 Prestwick1_000120 Prestwick2_000120 Prestwick3_000120 Prestwick_438 Rodinolone S1933_Selleck SK-Triamcinolone SMP1_000300 SMR000058333 SPBio_002079 Sk-Triamcinolone T6376_SIGMA TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7)) Tiamcinolonum Tiamcinolonum [INN-Latin] Tri-Nasal Triacet Triacort Triam-Tablinen Triamcet Triamcinalone Triamcinlon Triamcinolon Triamcinolona Triamcinolona [INN-Spanish] Triamcinolone (JP15/USP/INN) Triamcinolone [USAN:INN:BAN:JAN] Triamcinolone acetonide Triamcinolone diacetate Triamcinolone hexacetonide Triamcinolonum Triamcinolonum [INN] Triatex Tricortale Triderm Trilone Tristoject Trymex UNII-1ZK20VI6TY Vetalog Volon Volon A WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ ZINC03882036 droxypregna-1,4-diene-3,20-dione ione nchembio.2007.53-comp7 triamcinolone | |
| | 32 | | Cocaine | approved, illicit | Phase 4, Phase 2, Phase 1 | 501 | 50-36-2 | 5760, 446220 | (-)-Cocaine (-)-Cocaine base (1R,2R,3S,5S)-2-(methoxycarbonyl)tropan-3-yl benzoate (1R,2R,3S,5S)-2-Methoxycarbonyltropan-3-yl benzoate (R)-Cocaine (−)-cocaine 1-Cocaine 1i7z 1q72 2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester) 2-beta-Carbomethoxy-3-beta-benzoxytropane 2-beta-Tropanecarboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester) 2beta-Carbomethoxy-3beta-benzoxytropane 3-Tropanylbenzoate-2-carboxylic acid methyl ester 3beta-Hydroxy-2beta-tropanecarboxylic acid methyl ester benzoate (ester) 50-36-2 53-21-4 (hydrochloride) 610089_ALDRICH 610089_FLUKA AC-16037 AC-20208 AC1L1EK2 AC1L1L2T AC1L3U2D AC1L9JBL Allococaine Allopseudococaine Badrock Bazooka Benzoylethylecgonine Benzoylmethylecgonine Bernice Bernice [Street Name] Bernies Beta-Cocain Blast Blizzard Blow Blow [Street Name] Bouncing Powder Bump Burese C" Carrie C01416 C8912_SIGMA CHEBI:27958 CID11779748 CID2826 CID446220 CID5760 COC CPD-9776 Cabello Candy Carrie Caviar Cecil Cecil [Street Name] Charlie Chicken Scratch Cholly Coca Cocain Cocaina Cocaine Cocaine (TN) Cocaine (USP) Cocaine Free Base Cocaine [BAN] Cocaine free base Cocaine solution Cocaine-M Cocainum Cocktail Coke Cola Corine Crack Crack cocaine D-pseudococaine D00110 DB00907 DEA No. 9041 Dama Blanca Dama blanca Delcaine Depsococaine Dextrocaine DivK1c_000975 Dust EINECS 200-032-7 Ecgonine methyl ester benzoate Ecgonine methyl ester benzoate solution Ecgonine, methyl ester, benzoate (ester) | Eritroxilina Erytroxylin Flake Flake [Street Name] Flex Florida Snow Foo Foo Freeze G-Rock Girl Girl [Street Name] Gold Dust Gold dust Gold dust [Street Name] Goofball Green Gold Green gold HSDB 6469 Happy Dust Happy Powder Happy Trails Happy dust Happy dust [Street Name] Happy powder Happy trails Heaven Hell IDI1_000975 Isocaine Isococain Isococaine Jam KBio1_000975 Kibbles N' Bits Kibbles n' Bits Kokain Kokan Kokayeen L-Cocain L-Cocaine L000836 LS-157759 Lady Lady [Street Name] Leaf MLS002320697 Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate Methyl 3beta-hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylate benzoate (ester) Methyl Benzoylecgonine Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate Methyl benzoylecgonine MolPort-002-535-520 MolPort-003-937-722 Moonrocks NCGC00159467-02 NINDS_000975 Neurocaine Nose candy Pimp's Drug Pimp's drug Prime Time Pseudoallococaine Pseudococaine Rock Rock [Street Name] SMR001338843 STOCK1N-68258 Sleighride Snort Snow Snow (birds) Star Dust Star dust Star-Spangled Powder Star-spangled powder Sugar Sweet Stuff Toke Toot Toot [Street Name] Trails UNII-I5Y540LHVR White girl or lady Yeyo Zip [1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester beta-Cocain cocaine cocainum d-Pseudococaine l-Cocain methyl (1S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate methyl (3S,4R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate nchembio.284-comp4 | |
| | 33 | | Vincristine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 904 | 2068-78-2, 57-22-7 | 5978 | 22-Oxovincaleukoblastin 22-Oxovincaleukoblastine 28379-27-3 57-22-7 AC1L1LJC C07204 C46H56N4O10 CCRIS 5763 CHEBI:28445 CID5978 D08679 DB00541 EINECS 200-318-1 HMS2090E19 HSDB 3199 Indole alkaloid LCR LS-228 Leurocristine Lilly 37231 (1:1 sulfate salt) Liposomal Vincristine Marqibo NCGC00163700-01 NCI-C04864 NCI60_026703 NSC-67574 Onco TCS | Oncovin Oncovin (1:1 sulfate salt) Oncovine Tecnocris Tecnocris (TN) UNII-5J49Q6B70F VCR VIN Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine Vincasar Vincasar (1:1 sulfate salt) Vincasar PFS Vincrex Vincrex (1:1 sulfate salt) Vincristin Vincristina Vincristina [DCIT] Vincristine (INN) Vincristine Sulfate Vincristine Sulfate PFS Vincristine [INN:BAN] Vincristinum Vincristinum [INN-Latin] Vincrstine Vincrystine Vinkristin Z-D-Val-Lys(Z)-OH vincristine | |
| | 34 | | Sulfadiazine | approved, vet_approved | Phase 4, Phase 3 | 32 | 68-35-9 | 5215 | 141582-64-1 2-Sulfanilamido-pyrimidine 2-Sulfanilamidopyrimidin 2-Sulfanilamidopyrimidin [German] 2-Sulfanilamidopyrimidine 2-Sulfanilylaminopyrimidine 2-Sulfapyrimidine 2-sulfanilamidopyrimidine 2-sulfanilylaminopyrimidine 35033_FLUKA 35033_RIEDEL 4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide 4-Amino-N-2-pyrimidinyl- benzenesulfonamide 4-Amino-N-2-pyrimidinyl-benzenesulfonamide 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide 4-amino-N-2-pyrimidinylbenzenesulfonamide 4-amino-N-pyrimidin-2-ylbenzenesulfonamide 5-25-10-00067 (Beilstein Handbook Reference) 68-35-9 A 306 A-306 A-306 (VAN) AB00052095 AC-12001 AC1L1JUR AC1Q51XM AC1Q6W1E AI3-01047 AKOS000119073 AR-1L4215 Adiazin Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine Adiazine BB_SC-0628 BPBio1_000095 BRD-K32273377-001-05-4 BRN 0235192 BSPBio_000085 BSPBio_002884 C07658 C10H10N4O2S CAS-68-35-9 CHEBI:9328 CHEMBL439 CID5215 CRL-8131 & Sulfadiazine Coco-Diazine CocoDiazine Cocodiazine Codiazine Cremodiazine Cremotres D00587 D013411 DB00359 Debenal Deltazina Di-Azo-Mul Diazin Diazolone Diazovit Diazyl DivK1c_000543 EINECS 200-685-8 Eskadiazine HMS1568E07 HMS1921A13 HMS2090P09 HMS2092I15 HMS501L05 Honey Diazine Honey diazine IDI1_000543 KBio1_000543 KBio2_001466 KBio2_004034 KBio2_006602 KBio3_002104 KBioGR_000743 KBioSS_001466 LS-147838 Lantrisul Lipo-Diazine Lipo-Levazine Liquadiazine MLS000069423 Metha-Meridiazine Microsulfon Mixture of sulfadiazine, sulfamerazine, and sulfamethazine MolPort-000-629-738 N(1)-2-Pyrimidinylsulfanilamide N(1)-2-Pyrimidylsulfanilamide N(1)-2-pyrimidinylsulfanilamide N(1)-2-pyrimidylsulfanilamide N(sup 1)-2-Pyrimidinylsulfanilamide N(sup1)-2-Pyrimidinylsulfanilamide N(sup1)-2-Pyrimidylsulfanilamide N-(2-Pyrimidinyl)sulfanilamide | N1-(Pyrimidin-2-yl)sulfanilamide N1-2-pyrimidinylsulfanilamide N1-2-pyrimidylsulfanilamide NCGC00016305-01 NCGC00016305-02 NCGC00023291-03 NCGC00023291-04 NINDS_000543 NSC 35600 NSC117870 NSC35600 Neazine Neotrizine Oprea1_081078 Palatrize Pecta-Diazine Pecta-diazine, suspension Piridisir Pirimal Prestwick0_000023 Prestwick1_000023 Prestwick2_000023 Prestwick3_000023 Prestwick_428 Pyrimal Quadetts Quadramoid RP 2616 Recombinant bactericidal/permeability-increasing protein & Sulfadiazine S. N. 112 S.N. 112 S0579 S1770_Selleck S8626_SIGMA SDA SMR000059113 SPBio_001417 SPBio_002006 SPECTRUM1500546 SSD STK317797 Sanodiazine Sildaflo Silvadene Solfadiazina Solfadiazina [DCIT] Spectrum2_001319 Spectrum3_001362 Spectrum4_000342 Spectrum5_000992 Spectrum_000986 Spofadrizine Sterazine Sulfa-Triple #2 Sulfacombin Sulfadiazene Sulfadiazin Sulfadiazina Sulfadiazina [INN-Spanish] Sulfadiazine Sulfadiazine (JAN/USP/INN) Sulfadiazine (TN) Sulfadiazine [USAN:INN:JAN] Sulfadiazine, Zinc Sulfadiazinum Sulfadiazinum [INN-Latin] Sulfaloid Sulfanilamide, N1-2-pyrimidinyl- (8CI) Sulfanilamidopyrimidine Sulfapirimidin Sulfapyrimidin Sulfapyrimidin [German] Sulfapyrimidine Sulfatryl Sulfazine Sulfolex Sulfonamides Duplex Sulfonsol Sulfose Sulphadiazine Sulphadiazine E TL80073596 Terfonyl Theradiazine Thermazene Thi-Di-Mer Tri-Sulfameth Trifonamide Triple Sulfa Triple Sulfas Triple Sulfoid Trisem Trisulfapyrimidine, oral suspension Truozine UNII-0N7609K889 WLN: T6N CNJ BMSWR DZ ZINC00120319 Zinc Sulfadiazine rBPI21 & Sulfa sulfadiazine | |
| | 35 | | Darbepoetin alfa | approved, investigational | Phase 4, Phase 2, Phase 3 | 173 | 11096-26-7, 209810-58-2 | | Darbepoetin Darbepoetin alfa,recombinant | |
| | 36 | | Tranexamic Acid | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 257 | 1197-18-8 | 5526 | 08455_FLUKA 1197-17-7 1197-18-8 1ceb 3-14-00-00868 (Beilstein Handbook Reference) 4-(Aminomethyl)-Cyclohexanecarboxylic Acid 4-(Aminomethyl)cyclohexanecarboxylic acid 4-(aminomethyl)cyclohexane-1-carboxylic acid 857653_ALDRICH A0236 AB00052260 AB1003647 AC-4687 AC1L1KJH AC1Q50F3 AC1Q546D AC1Q5U04 ALBB-006013 AMCA AMCHA AMH AR-1F6595 Acide tranexamique Acide tranexamique [INN-French] Acido tranexamico Acido tranexamico [INN-Spanish] Acidum tranexamicum Acidum tranexamicum [INN-Latin] Amikapron Amstat Anvitoff BAY 3517 BPBio1_000069 BRN 2207452 BSPBio_000061 BSPBio_002837 CAS-1197-18-8 CHEBI:48669 CHEMBL292500 CHEMBL877 CID5526 CL 65336 CL-65336 Carxamin Cyclocapron Cyklokapron Cyklokapron (TN) D01136 DB00302 DV 79 DV-79 DV79 DivK1c_000655 EINECS 214-818-2 Emorhalt Exacyl Frenolyse HMS1568D03 HMS1921F08 HMS2092P03 HMS502A17 Hexapromin Hexatron I04-0993 IDI1_000655 KABI 2161 KBio1_000655 KBio2_001871 KBio2_004439 KBio2_007007 KBio3_002337 KBioGR_000511 | KBioSS_001871 LS-56611 LS-56612 LT00159441 Mastop MolPort-001-792-390 MolPort-002-512-008 NCGC00016569-01 NCGC00016569-02 NCGC00016569-03 NCGC00094944-01 NCGC00094944-02 NINDS_000655 NSC 291305 NSC291305 Oprea1_786414 Prestwick0_000171 Prestwick1_000171 Prestwick2_000171 Prestwick3_000171 Prestwick_476 RP 18,429 Rikavarin Rikavarin (TN) Rikavarin-S SPBio_000689 SPBio_001982 SPECTRUM1502026 STK503668 STOCK1N-16183 Spectrum2_000655 Spectrum3_001189 Spectrum4_000046 Spectrum5_001258 Spectrum_001391 Spiramin Tamcha Tranex Tranexamate Tranexamic acid (JP15/USAN/INN) Tranexamic acid [USAN:INN:BAN:JAN] Tranexamic acid cis-form Tranexamsaeure Tranexan Tranexmic acid Tranhexamic acid Trans AMCHA Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid Trans-p-(Aminomethyl)cyclohexanecarboxylic Transamin Transamin (TN) Transamlon Trasamlon UNII-6T84R30KC1 Ugurol WLN: L6TJ AVQ D1Z -T cis-4-(Aminomethyl)cyclohexanecarboxylic acid cis-4-Aminomethylcyclohexane-1-carboxylic acid cis-AMCHA t-AMCHA tranexamic acid tranexmic acid trans-1-Aminomethylcyclohexane-4-carboxylic acid trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid trans-4-(Aminomethyl)cyclohexane-carboxylic acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester trans-4-Aminomethylcyclohexane-1-carboxylic acid trans-4-aminomethylcyclohexane-1-carboxylic acid trans-Amcha trans-Tranexamic acid trans-p-(Aminomethyl)cyclohexanecarboxylic acid | |
| | 37 | | Midazolam | approved, illicit | Phase 4, Phase 3, Phase 2, Phase 1 | 684 | 59467-70-8 | 4192 | 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate 59467-70-8 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine AC-18749 AC1L1HMA BIDD:GT0647 BRN 0625572 Buccolam C07524 C18H13ClFN3 CHEMBL655 CID4192 D00550 DB00683 DEA No. 2884 Dazolam Dea No. 2884 | Dormicum Dormicum (TN) EINECS 261-774-5 LS-77780 Midanium Midazolam Midazolam (JAN/INN) Midazolam Base Midazolam Hcl Midazolam [INN:BAN:JAN] Midazolamum Midazolamum [INN-Latin] Midosed MolPort-003-849-219 NCGC00168254-01 Ro 21-3981 TL8003787 UC429_SIGMA UNII-R60L0SM5BC Versed ZINC00001732 midazolam nchembio747-comp32 |
| | 38 | | Sorafenib | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 692 | 284461-73-0 | 216239, 406563 | 284461-73-0 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE AB1004622 AC-1674 AC1L50CF BAX BAY 43-9006 BAY 43-9006 (free base) BAY 43-9006 tosylate salt BAY 439006 BAY 54-9085 (tosylate salt) BAY-43-0006 BAY-43-9006 BAY-54-9085 BAY43-9006 BRD-K23984367-001-01-8 Bio-0100 CHEBI:47228 CHEBI:50924 CHEMBL1336 CID216239 | D08524 DB00398 DB07438 EN002709 I06-0856 K00597a Kinome_766 LS-186067 LS-187021 LS-187788 MolPort-003-850-270 N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea NCGC00167488-01 NSC-724772 NSC747971 Nexavar STK627350 Sorafenib Sorafenib (INN) Sorafenib [INN] Sorafenib tosylate Sorafenibum UNII-9ZOQ3TZI87 ZINC01493878 nchembio.117-comp17 sorafenib sorafenibum | |
| | 39 | | Octreotide | approved, investigational | Phase 4, Phase 2, Phase 3 | 213 | 83150-76-9 | 383414, 6400441 | (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 79517-01-4 (acetate salt) 83150-76-9 AC1L1GVU AC1L8LCD AC1L9M4X C07306 C5H12O2.C4H10 CHEBI:427278 CHEBI:611465 CHEMBL1680 CID383414 CID448601 CID54374 D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide D00442 DRG-0115 HMS2090C09 HS-2020 | L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R* L000453 LS-177735 LS-187135 Longastatin NCGC00181796-01 NCI60_025753 Octreotida Octreotida [Spanish] Octreotide Octreotide (USAN/INN) Octreotide Acetate Salt Octreotide [USAN:INN:BAN] Octreotide-LAR Octreotidum Octreotidum [Latin] Octrotide SAN 201-995 SM 201-995 SMS 201-995 SMS-201-995 Sandostatine Sandoz 201-995 UNII-RWM8CCW8GP nchembio.184-comp3 zacycloicosane-4-carboxamide acetate |
| | 40 | | Adenosine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 397 | 58-61-7 | 60961 | (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose 1odi 2fqy 2gl0 30143-02-3 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside 46946-45-6 46969-16-8 58-61-7 6-Amino-9-.beta.-ribofuranosyl-9H-purine 6-Amino-9-beta-D-ribofuranosyl-9H-purine 6-Amino-9beta-D-ribofuranosyl-9H-purine 6-Amino-9beta-delta-ribofuranosyl-9H-purine 9-(beta-D-Arabinofuranosyl)adenine 9-beta-D-Arabinofuranosyladenine 9-beta-D-Ribofuranosidoadenine 9-beta-D-Ribofuranosyl-9H-purin-6-amine 9-beta-D-Ribofuranosyladenine 9-beta-delta-Arabinofuranosyladenine 9-beta-delta-Ribofuranosidoadenine 9-beta-delta-Ribofuranosyl-9H-purin-6-amine 9-beta-delta-Ribofuranosyladenine 9beta-D-Ribofuranosyladenine 9beta-D-ribofuranosyl-9H-Purin-6-amine 9beta-delta-Ribofuranosyladenine 9beta-delta-ribofuranosyl-9H-Purin-6-amine A0152 A4036_SIGMA A9251_SIGMA AC1L1U8O AC1Q1ID3 AC1Q52XU ADN AI3-52413 Ade-Rib Ade-rib Adenin riboside Adenine 9-beta-D-arabinofuranoside Adenine deoxyribonucleoside Adenine nucleoside Adenine riboside Adenine-9-beta-D-ribofuranoside Adenine-9beta-D-Ribofuranoside Adenine-9beta-delta-Ribofuranoside Adenocard Adenocard (TN) Adenocard, Adenosine Adenocor Adenoscan Adenoscan (TN) Adenosin Adenosin [German] Adenosina Adenosine (JAN/USP) Adenosine [USAN:BAN] Adenosine, homopolymer Adenosinum Adensoine Adenyldeoxyriboside Ado Adénosine BB_NC-0565 BSPBio_001796 Bio1_000437 | Bio1_000926 Bio1_001415 Boniton C00212 CCRIS 2557 CHEBI:16335 CHEMBL477 CID60961 Caswell No. 010B D000241 D00045 DB00640 Deoxyadenosine Desoxyadenosine EA6C60C2-6AFB-4264-A2F0-541373DB950E EINECS 200-389-9 FT-0082881 HMS1920A13 HMS2091G13 KBio3_001296 LS-15085 MEDR-640 MLS000069638 MLS002153227 MolPort-001-838-229 Myocol NCGC00023673-03 NCGC00023673-04 NCGC00023673-05 NCGC00023673-06 NCGC00023673-07 NSC 627048 NSC 7652 NSC627048 NSC7652 Nucleocardyl Pallacor Polyadenosine Polyriboadenosine S1647_Selleck SDCCGMLS-0003108.P003 SMR000058216 SPBio_001194 SPECTRUM1500107 SR 96225 SR-96225 SUN-Y4001 Sandesin Spectrum2_001257 Spectrum3_000288 TL8003749 UNII-K72T3FS567 USAF CB-10 V0098 Vidarabine ZINC02169830 adenine-D-ribose adenosine b-D-Adenosine beta-Adenosine beta-D-Adenosine beta-D-Ribofuranoside, adenine-9 beta-delta-Adenosine bmse000061 nchembio.143-comp9 nchembio.186-comp109 nchembio.2007.56-comp13 nchembio.64-comp4 nchembio706-5 |
| | 41 | | Terlipressin | approved, investigational | Phase 4, Phase 2 | 49 | 14636-12-5 | 72081 | (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide (2s)-1-{[(4r,7s,10s,13s,16s,19r)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-n-{(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide(non-preferred name) 14636-12-5 AC1L2HDP AC1Q5JB2 CID72081 DB02638 EINECS 238-680-8 HS-2028 LS-161411 | Lucassin N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Terlipressin Terlipressin [BAN:INN] Terlipressina Terlipressina [INN-Spanish] Terlipressine Terlipressine [INN-French] Terlipressinum Terlipressinum [INN-Latin] UNII-7Z5X49W53P glypressin |
| | 42 | | Somatostatin | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 229 | 38916-34-6, 51110-01-1 | 53481605 | growth hormone-inhibiting hormone (GHIH) | somatotropin release-inhibiting factor (SRIF) somatotropin release-inhibiting hormone | |
| | 43 | | Deferasirox | approved, investigational | Phase 4, Phase 2 | 89 | 201530-41-8 | 5493381 | Deferasiroxum Deferasiroxum [inn-latin] | Exjade ICL 670 ICL 670a deferasirox |
| | 44 | | Lidocaine | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1226 | 137-58-6 | 3676 | .alpha.-(Diethylamino)-2,6-acetoxylidide .alpha.-Diethylamino-2,6-dimethylacetanilide .alpha.-Diethylaminoaceto-2,6-xylidide .omega.-Diethylamino-2,6-dimethylacetanilide 137-58-6 2-(Diethylamino)-2',6'-acetoxylidide 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide 4-12-00-02538 (Beilstein Handbook Reference) 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)) 6108-05-0 (mono-hydrochloride, mono-hydrate) 73-78-9 (mono-hydrochloride) AB00053581 AC-10282 AC1L1GGQ AC1Q2Z7J AKOS001026768 ARONIS23855 After Burn Double Strength Gel After Burn Double Strength Spray After Burn Gel After Burn Spray Alphacaine Anestacon Anestacon Jelly BIDD:GT0342 BPBio1_000197 BRD-K52662033-001-02-6 BRD-K52662033-003-05-5 BRN 2215784 BSPBio_000179 BSPBio_001359 BSPBio_003004 Bio-0767 Bio1_000379 Bio1_000868 Bio1_001357 Bio2_000079 Bio2_000559 C07073 C14H22N2O CAS-73-78-9 CDS1_000283 CHEBI:6456 CHEMBL79 CID3676 CPD000058189 Cappicaine Cito optadren Cuivasil D00358 DB00281 Dalcaine Dentipatch Dentipatch (TN) DermaFlex Diethylaminoaceto-2,6-xylidide Dilocaine DivK1c_000174 DivK1c_001323 Duncaine EINECS 205-302-8 ELA-Max EMBOLEX Emla Emla Cream Esracaine FT-0082378 Gravocain HMS1791D21 HMS1989D21 HMS2051C21 HMS2089E15 HMS548M19 HSDB 3350 I01-2704 IDI1_000174 IDI1_033829 Isicaina Isicaine Jetocaine KBio1_000174 KBio2_000079 KBio2_001598 KBio2_002647 KBio2_004166 KBio2_005215 KBio2_006734 KBio3_000157 KBio3_000158 KBio3_002224 KBioGR_000079 KBioGR_000599 KBioSS_000079 KBioSS_001598 L-Caine L0156 L1026_SIGMA L7757_SIGMA LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE) LIDOPEN LQZ | LS-805 Lanabiotic Leostesin Lida-Mantle Lidocaina Lidocaina [INN-Spanish] Lidocaine (JP15/USP/INN) Lidocaine (VAN) Lidocaine Carbonate Lidocaine Hydrocarbonate Lidocaine Monohydrochloride Lidocaine [USAN:INN:JAN] Lidocainum Lidocainum [INN-Latin] Lidocaton Lidoderm Lidoject-1 Lidoject-2 Lignocaine Lignocainum Lingocaine Lopac-L-5647 Lopac0_000669 MLS000069724 MLS000758263 MLS001074177 Maricaine Maybridge1_002571 MolPort-001-783-478 N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide NCGC00015611-01 NCGC00015611-02 NCGC00015611-03 NCGC00015611-04 NCGC00015611-14 NCGC00022176-05 NCGC00022176-06 NCGC00022176-07 NCGC00022176-08 NCGC00022176-09 NINDS_000174 NSC 40030 NSC40030 Norwood Sunburn Spray Octocaine Octocaine-100 Octocaine-50 Prestwick0_000050 Prestwick1_000050 Prestwick2_000050 Prestwick3_000050 Remicaine Rocephin Kit Rucaina S1357_Selleck SAM001247018 SMR000058189 SPBio_001525 SPBio_002100 STK552033 Solarcaine Solarcaine aloe extra burn relief cream Solcain Spectrum2_001343 Spectrum3_001392 Spectrum4_000070 Spectrum5_001549 Spectrum_001118 UNII-98PI200987 WLN: 2N2 & 1VMR B1 F1 Xilina Xilocaina Xilocaina [Italian] Xllina Xycaine Xylestesin Xylesthesin Xylocain Xylocaine Xylocaine (TN) Xylocaine 5% Spinal Xylocaine CO2 Xylocaine Dental Ointment Xylocaine Endotracheal Xylocaine Test Dose Xylocaine Viscous Xylocaine-MPF Xylocaine-MPF with Glucose Xylocaine-Mpf Xylocaine-Mpf with Glucose Xylocard Xylocitin Xyloneural (free base) Xylotox Zilactin-L Zingo alfa-Dietilamino-2,6-dimetilacetanilide alfa-Dietilamino-2,6-dimetilacetanilide [Italian] alpha-Diethylamino-2,6-dimethylacetanilide alpha-diethylamino-2,6-dimethylacetanilide lidocaine nchembio.65-comp16 α-diethylamino-2,6-dimethylacetanilide | |
| | 45 | | Estradiol | approved, investigational, vet_approved | Phase 4, Phase 2, Phase 1 | 1283 | 50-28-2 | 5757, 53477783 | (+)-3,17b-Estradiol (17b)-Estra-1,3,5(10)-triene-3,17-diol (17beta)-Estra-1,3,5(10)-triene-3,17-diol .alpha.-Estradiol .alpha.-Oestradiol .beta.-Estradiol .beta.-Oestradiol 1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate 1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol 17 beta-Estradiol 17-.BETA.-Estradiol 17-E 17-beta 17-beta-OH-estradiol 17-beta-estradiol 17.beta.-Estradiol 17.beta.-Oestradiol 17E 17b-Estradiol 17b-Oestradiol 17beta Oestradiol 17beta oestradiol 17beta-Estra-1,3,5(10)-triene-3,17-diol 17beta-Estradiol 17beta-Oestradiol 1jgl 1qkt 1qku 2d06 3,17-Epidihydroxyestratriene 3,17-beta-Estradiol 3,17-beta-Oestradiol 3,17.beta.-Estradiol 3,17b-Dihydroxyestra-1,3,5(10)-triene 3,17b-Estradiol 3,17beta-Estradiol 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate 50-28-2 73459-61-7 873662-39-6 AC-10460 AC1L1L2K Aerodiol Agofollin Alora Altrad Amnestrogen Aquadiol B-Estradiol BEDOs BIDD:ER0125 BIDD:PXR0065 BPBio1_000532 BSPBio_000482 BSPBio_001065 Bardiol Benzhormovarine Beta-estradiol Bio-0812 Bio-E-Gel Bio1_000403 Bio1_000892 Bio1_001381 Bio2_000363 Bio2_000843 C00951 C18H24O2 CCRIS 280 CHEBI:16469 CHEMBL135 CID5757 CMC_11154 CPD-352 CPD000059126 Climaderm Climara Climara (TN) Climara Forte Compudose Compudose 200 Compudose 365 Corpagen D-3,17beta-Estradiol D-Estradiol D-Oestradiol D00105 DB00783 Dermestril Destradiol Dihydro-Theelin Dihydrofollicular hormone Dihydrofolliculin Dihydromenformon Dihydrotheelin Dihydroxyesterin Dihydroxyestrin Dihydroxyoestrin Dimenformon Diogyn Diogynets Divigel Divigel (TN) E 2 E 8875 E(sub 2) E0025 E1024_SIGMA E1132_SIGMA E2257_SIGMA E2758_SIGMA E8875_SIGMA EINECS 200-023-8 EU-0100503 Elestrin Encore Epiestriol 50 Esclim Estra-1,3,5(10)-triene-3,17b-diol Estrace Estrace (TN) Estraderm Estraderm (TN) Estraderm MX Estraderm TTS Estraderm TTS 100 Estraderm TTS 50 Estradiol Estradiol [USAN:INN] Estradiol-17 beta Estradiol-17-beta Estradiol-17.beta. Estradiol-17beta Estradiol-3,17beta Estradiolo Estradiolo [DCIT] Estradiolum Estradiolum [INN] Estradot Estraldine Estrapak 50 Estrasorb Estrasorb (TN) Estreva Estrifam Estring Estring (TN) Estring Vaginal Ring Estring vaginal ring Estroclim Estroclim 50 Estrodiolum Estrofem 2 Estrofem Forte Estrogel | Estrogel (TN) Estrogel HBF Estrovite Evamist Evorel Extrasorb Femanest Femestral Femestrol Femogen Fempatch Femtrace Femtran Follicyclin Gelestra Ginedisc Ginosedol GynPolar Gynergon Gynestrel Gynodiol Gynoestryl HMS1362E07 HMS1569I04 HMS1792E07 HMS1990E07 HMS2051C17 HMS2090E18 HSDB 3589 IDI1_002118 Innofem Innofem (TN) KBio2_000405 KBio2_002269 KBio2_002973 KBio2_004837 KBio2_005541 KBio2_007405 KBio3_000769 KBio3_000770 KBio3_002749 KBioGR_000405 KBioGR_002269 KBioSS_000405 KBioSS_002270 LMST02010001 LS-137 Lamdiol Lio-Oid Lopac0_000503 MLS000069494 MLS000758312 MLS001076331 Macrodiol Macrol Menest Menorest Menostar Microdiol MolPort-001-794-632 NCGC00091544-00 NCGC00091544-01 NCGC00091544-02 NCGC00091544-04 NCGC00091544-05 NCGC00091544-06 NCGC00091544-07 NCGC00091544-08 NCGC00091544-09 NCGC00091544-12 NCGC00179321-01 NCGC00179321-02 NSC-9895 NSC9895 Nordicol Oesclim Oestergon Oestra-1,3,5(10)-triene-3,17b-diol Oestradiol Oestradiol Berco Oestradiol R Oestradiol-17-beta Oestradiol-17.beta. Oestradiol-17beta Oestradiolum Oestrogel Oestroglandol Oestrogynal Ovahormon Ovasterol Ovastevol Ovociclina Ovocyclin Ovocycline Ovocylin Perlatanol Polyestradiol Prestwick0_000441 Prestwick1_000441 Prestwick2_000441 Prestwick3_000441 Prestwick_207 Primofol Profoliol Profoliol B Progynon Progynon DH Progynon-DH S-21400 S1709_Selleck SAM001247032 SK-Estrogens SL-1100 SMP1_000121 SMR000059126 SPBio_002421 Sandrena 1 Sandrena Gel Sisare Gel Spectrum5_002055 Syndiol Systen Tradelia Trial SAT Trocosone UNII-4TI98Z838E VIVELLE-DOT Vagifem Vagifem (TN) Vivelle Vivelle (TN) Zerella Zesteem Zesteen Zumenon [2,4,6,7-3H]-E2 [3H]-estradiol [3H]]estradiol b-Estradiol beta-Estradiol beta-Estradiol 3-sulfate beta-Estradiol 3-sulphate bmse000642 cMAP_000005 cis-Estradiol cis-Oestradiol component of Menrium delta-Estradiol delta-Oestradiol estradiol estradiol-17beta nchembio.168-comp3 nchembio.76-comp2 nchembio775-comp2 nchembio794-comp6 nchembio860-comp1 progynon | |
| | 46 | | Milnacipran | approved | Phase 4 | 59 | 92623-85-3 | 65833 | ( -)-Milnacipran (+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide (-)-milnacipran (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide 1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl 105310-09-6 92623-85-3 AC1L2425 CHEMBL252923 CID65833 D08222 DB04896 F 2207 | F-2207 F2207 Ixel LS-178180 Midalcipran Milnacipran Milnacipran (INN) Milnacipran [INN] Milnacipranum Milnacipranum [Latin] Milnacipranum [latin] NCGC00165825-01 Toledomin UNII-G56VK1HF36 milnacipran |
| | 47 | | Benzocaine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1892 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 48 | | Amiodarone | approved, investigational | Phase 4, Phase 3, Phase 2 | 120 | 1951-25-3 | 2157 | (2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone (2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone (2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone (2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone (2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine 1951-25-3 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran 2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran 2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran 2-Butyl-3-[3,5-diiodo-4-(2-di 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone 2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone 2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone 2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran 5-18-02-00353 (Beilstein Handbook Reference) AB00053422 AC1L1D1R AC1Q2VCU ASTA Medica Brand of Amiodarone Hydrochloride Alphapharm Brand of Amiodarone Hydrochloride Amidorone Aminodarone Amio-Aqueous IV Amiobeta Amiodarex Amiodarona Amiodarona [INN-Spanish] Amiodarone Amiodarone (USAN/INN) Amiodarone Base Amiodarone HCL Amiodarone Hydrochloride Amiodarone [USAN:BAN:INN] Amiodarons Amiodaronum Amiodaronum [INN-Latin] Amiohexal Amjodaronum Ancar Aratac Armstrong Brand of Amiodarone Hydrochloride Arycor BIDD:GT0425 BIDD:PXR0146 BPBio1_000372 BRN 1271711 BSPBio_000338 BSPBio_001574 BSPBio_002580 Berenguer Infale Brand of Amiodarone Hydrochloride Betapharm Brand of Amiodarone Hydrochloride Bio1_000026 Bio1_000515 Bio1_001004 Bio2_000294 Bio2_000774 Braxan C06823 C25H29I2NO3 CAS-19774-82-4 CBiol_001740 CHEBI:2663 CHEMBL633 CID2157 Corbionax Cordarex Cordarone Cordarone Intravenous D000638 D02910 DB01118 DivK1c_000079 EINECS 217-772-1 | G Gam Brand of Amiodarone Hydrochloride HMS1791O16 HMS1989O16 HMS2089C07 Hexal Brand of Amiodarone Hydrochloride IDI1_000079 IDI1_034044 KBio1_000079 KBio2_000294 KBio2_000741 KBio2_002862 KBio2_003309 KBio2_005430 KBio2_005877 KBio3_000587 KBio3_000588 KBio3_001800 KBioGR_000294 KBioGR_001859 KBioSS_000294 KBioSS_000741 Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI) Kordaron L 3428 L-3428 L001174 L3428 LS-87088 Labaz Leurquin Brand of Amiodarone Hydrochloride Lopac-A-8423 Lopac0_000122 MolPort-003-703-670 NCGC00015096-01 NCGC00015096-02 NCGC00015096-03 NCGC00015096-10 NCGC00024242-03 NCGC00024242-04 NCGC00024242-05 NCGC00024242-06 NCI60_041885 NINDS_000079 Ortacrone Pacerone Pharma Investi Brand of Amiodarone Hydrochloride Prestwick0_000409 Prestwick1_000409 Prestwick2_000409 Prestwick3_000409 QTL1_000008 Rytmarone SKF 33134-A SKF 33134A SPBio_001825 SPBio_002277 STK529812 STOCK1S-12240 Sanofi Winthrop Brand of Amiodarone Hydrochloride Sedacoron Sedacorone Spectrum2_001813 Spectrum3_001050 Spectrum4_001190 Spectrum5_001533 Spectrum_000261 Tachydaron UNII-N3RQ532IUT UNM000001215003 Wyeth Brand of Amiodarone Hydrochloride amiodarone ethylaminoethoxy)benzoyl]benzofuran nchembio.79-comp9 nchembio732-comp1 on pms-Amiodarone |
| | 49 | | Haloperidol | approved | Phase 4, Phase 2 | 141 | 52-86-8 | 3559 | 1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine 4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone 4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one 5-21-02-00377 (Beilstein Handbook Reference) 52-86-8 AB00052008 AC-19691 AC1L1G7K AC1Q77Z0 AKOS000280660 ALDO Aldo Aloperidin Aloperidol Aloperidolo Aloperidolo [DCIT] Aloperidolo [Italian] Aloperidon Apo-Haloperidol BIDD:GT0128 BPBio1_000144 BPBio1_001231 BRD-K67783091-001-04-8 BRD-K67783091-001-05-5 BRN 0331267 BSPBio_000130 BSPBio_002096 Bio-0705 Biomol-NT_000035 Bioperidolo Brotopon C01814 C21H23ClFNO2 CAS-52-86-8 CCRIS 1630 CHEBI:5613 CHEMBL54 CID3559 D00136 D006220 DB00502 DivK1c_000654 Dozic Dozix EINECS 200-155-6 EU-0100583 Einalon S Eukystol Fortunan Galoperidol H 1512 H0912 H1512_SIGMA HMS1568G12 HMS1920D03 HMS2089M15 HMS2091J09 HMS502A16 HSDB 3093 Haldol Haldol Decanoate Haldol La Haldol Solutab Halidol Halojust Halol Halopal Haloperido Haloperidol (JP15/USP) Haloperidol (JP15/USP/INN) Haloperidol Decanoate Haloperidol Intensol Haloperidol Lactate Haloperidol [USAN:INN:BAN:JAN] Haloperidolum Haloperidolum [INN-Latin] Halopidol Halopoidol Halosten I14-13404 I14-14165 IDI1_000654 | KBio1_000654 KBio2_001341 KBio2_002390 KBio2_003909 KBio2_004958 KBio2_006477 KBio2_007526 KBio3_001316 KBio3_002869 KBioGR_000980 KBioGR_002390 KBioSS_001341 KBioSS_002395 Keselan L000288 LS-48311 Lealgin Compositum Lealgin compositum Linton Lopac-H-1512 Lopac0_000583 MLS000028450 MLS001146904 McN-JR-1625 Mixidol MolPort-000-883-311 NCGC00015500-01 NCGC00015500-02 NCGC00015500-06 NCGC00015500-14 NCGC00016234-01 NCGC00023875-02 NCGC00023875-04 NCGC00023875-05 NCGC00023875-06 NCGC00023875-07 NCGC00023875-08 NCGC00023875-09 NINDS_000654 NSC 170973 NSC 615296 NSC170973 NSC615296 Novo-Peridol Oprea1_509923 Pekuces Peluces Peridol Pernox Pms Haloperidol Prestwick0_000115 Prestwick1_000115 Prestwick2_000115 Prestwick3_000115 Prestwick_250 Probes1_000255 Probes2_000296 QTL1_000042 R 1625 R-1625 S1920_Selleck SMR000058303 SPBio_001236 SPBio_002069 SPECTRUM1500325 Serenace Serenase Serenelfi Sernas Sernel Sigaperidol Spectrum2_001268 Spectrum3_000448 Spectrum4_000570 Spectrum5_000788 Spectrum_000861 Tocris-0931 UNII-J6292F8L3D Ulcolind Uliolind Vesalium WLN: T6NTJ A3VR DF& DQ DR DG cMAP_000037 gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone haloperidol | |
| | 50 | | Nebivolol | approved, investigational | Phase 4 | 82 | 152520-56-4, 99200-09-6, 118457-14-0 | 71301 | 1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol 1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol 104365-59-5 118457-14-0 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] 99200-09-6 AC-1611 AC1L2FX8 AC1Q4OMF Bystolic C22H25F2NO4 CHEMBL434394 CID71301 D05127 DB04861 I06-0378 L001284 LS-178404 Lobivon MolPort-003-849-343 Narbivolol | Nebicard-5 Nebilet Nebilong Nebipill Nebivolol Nebivolol (USAN/INN) Nebivolol [USAN:INN:BAN] Nebivololum Nebivololum [Latin] Nebivololum [latin] Nubeta PDSP1_000244 PDSP2_000243 PI-21858 R 67555 R-67555 R65,824 UNII-030Y90569U alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol) alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol) | |
|
Interventional clinical trials: (show top 50)
(show all 5000)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Compression Aided Management of Edema in Patients With C3 Venous Disease | Unknown status | NCT00766974 | Phase 4 | | 2 | ClosureFAST - Radiofrequency Great Saphenous Vein Treatment | Unknown status | NCT00842296 | Phase 4 | | 3 | Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis | Unknown status | NCT01245998 | Phase 4 | | 4 | Rosuvastatin for Preventing Deep Vein Thrombosis | Unknown status | NCT01021488 | Phase 4 | | 5 | Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis | Unknown status | NCT00640731 | Phase 4 | | 6 | Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings | Unknown status | NCT01793194 | Phase 4 | | 7 | Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy | Unknown status | NCT02264743 | Phase 4 | | 8 | Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery | Unknown status | NCT01147419 | Phase 4 | | 9 | Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients | Unknown status | NCT01138254 | Phase 4 | | 10 | Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) | Unknown status | NCT01735227 | Phase 4 | | 11 | Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study | Unknown status | NCT01064323 | Phase 4 | | 12 | Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) | Unknown status | NCT00813332 | Phase 4 | | 13 | Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery | Unknown status | NCT01171911 | Phase 4 | | 14 | Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding | Unknown status | NCT00966355 | Phase 4 | | 15 | Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery | Unknown status | NCT01091389 | Phase 4 | | 16 | AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy | Unknown status | NCT02024308 | Phase 4 | | 17 | Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI | Unknown status | NCT00476944 | Phase 4 | | 18 | Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement | Unknown status | NCT01331902 | Phase 4 | | 19 | Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) | Unknown status | NCT01173094 | Phase 4 | | 20 | Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins | Unknown status | NCT02054325 | Phase 4 | | 21 | Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients | Unknown status | NCT01610141 | Phase 4 | | 22 | Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia | Unknown status | NCT01990807 | Phase 4 | | 23 | Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | Unknown status | NCT01833299 | Phase 4 | | 24 | Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium | Unknown status | NCT01783314 | Phase 4 | | 25 | Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections | Unknown status | NCT01142934 | Phase 4 | | 26 | Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding | Unknown status | NCT00965900 | Phase 4 | | 27 | Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis | Unknown status | NCT00450645 | Phase 4 | | 28 | Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery | Unknown status | NCT01229202 | Phase 4 | | 29 | Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users | Unknown status | NCT01063426 | Phase 4 | | 30 | Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism | Unknown status | NCT02127840 | Phase 4 | | 31 | Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding | Unknown status | NCT00966121 | Phase 4 | | 32 | Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding in Pts With Previous Variceal Treatment | Unknown status | NCT00966082 | Phase 4 | | 33 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC | Unknown status | NCT01997957 | Phase 4 | | 34 | Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol | Unknown status | NCT01174290 | Phase 4 | | 35 | Pulmonary Vein (PV) -Isolation: Arrhythmogenic Vein(s) Versus All Veins | Unknown status | NCT00605748 | Phase 4 | | 36 | Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women | Unknown status | NCT01827280 | Phase 4 | | 37 | Alster-Lost-AF-Study | Unknown status | NCT00820625 | Phase 4 | | 38 | Quadripolar Leads for the Management of Heart Failure Patients in the Middle East | Unknown status | NCT02195843 | Phase 4 | | 39 | EZIO Compared to Central Venous Lines for Emergency Vascular Access | Unknown status | NCT00785252 | Phase 4 | | 40 | Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . | Unknown status | NCT02032303 | Phase 4 | | 41 | Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel | Unknown status | NCT02032290 | Phase 4 | | 42 | Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis | Unknown status | NCT01252420 | Phase 4 | | 43 | The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation | Unknown status | NCT01629056 | Phase 4 | | 44 | Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy | Unknown status | NCT01857544 | Phase 4 | | 45 | A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® | Unknown status | NCT02011724 | Phase 4 | | 46 | Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis | Unknown status | NCT01350206 | Phase 4 | | 47 | Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO | Unknown status | NCT00566761 | Phase 4 | | 48 | A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy | Unknown status | NCT00773539 | Phase 4 | | 49 | Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis | Unknown status | NCT01376817 | Phase 4 | | 50 | Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia | Unknown status | NCT01509274 | Phase 4 |
|
